NVRO
NVRO Real Time Price USDRecent trades of NVRO by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in NVRO holdings by institutional investors
Quarterly net insider trading by NVRO's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$40,000 Sep 25, 2025 Issue: Medicare/Medicaid
-
$40,000 Jul 18, 2025 Issue: Medicare/Medicaid
-
$40,000 Apr 17, 2025 Issue: Medicare/Medicaid
-
$40,000 Oct 17, 2024 Issue: Medicare/Medicaid
-
$40,000 Jul 15, 2024 Issue: Medicare/Medicaid
-
$40,000 Apr 17, 2024 Issue: Medicare/Medicaid
-
$40,000 Oct 20, 2023 Issue: Medicare/Medicaid
-
$40,000 Jul 20, 2023 Issue: Medicare/Medicaid
-
$10,000 Jul 20, 2020 Issue: Medicare/Medicaid
-
$30,000 Jun 03, 2020 Issue: Medicare/Medicaid
-
$30,000 Jan 21, 2020 Issue: Medicare/Medicaid Taxation/Internal Revenue Code
-
$30,000 Oct 18, 2019 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
-
$30,000 Jul 12, 2019 Issue: Medicare/Medicaid
-
$30,000 Apr 04, 2019 Issue: Medicare/Medicaid
-
$40,000 Jan 09, 2019 Issue: Medicare/Medicaid
-
$40,000 Oct 10, 2018 Issue: Medicare/Medicaid
-
$50,000 Jul 17, 2018 Issue: Health Issues
-
$40,000 Jul 09, 2018 Issue: Medicare/Medicaid
-
$30,000 Jan 19, 2018 Issue: Health Issues Medicare/Medicaid
NVRO Estimated quarterly lobbying spending
NVRO Revenue by Segment or Geography
New NVRO patent grants
-
Patent Title: External neurostimulator Apr. 25, 2023
-
Patent Title: Handheld remote controller Sep. 27, 2022
-
Patent Title: Charger controller Apr. 05, 2022
-
Patent Title: Devices for controlling high frequency spinal cord modulation for inhibiting pain, and associated systems and methods, including simplified program selection Jun. 12, 2018
-
Patent Title: Systems and methods for selecting low-power, effective signal delivery parameters for an implanted pulse generator Apr. 10, 2018
-
Patent Title: Methods and systems for disease treatment using electrical stimulation Feb. 20, 2018
-
Patent Title: Systems and methods for deploying patient therapy devices Feb. 20, 2018
-
Patent Title: Systems and methods for extending the life of an implanted pulse generator battery Feb. 06, 2018
-
Patent Title: Physician programmer with enhanced graphical user interface, and associated systems and methods Jan. 16, 2018
-
Patent Title: Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods Dec. 05, 2017
-
Patent Title: Linked area parameter adjustment for spinal cord stimulation and associated systems and methods Nov. 28, 2017
-
Patent Title: Systems and methods for detecting faults and/or adjusting electrical therapy based on impedance changes Nov. 14, 2017
-
Patent Title: Couplings for implanted leads and external stimulators, and associated systems and methods Oct. 17, 2017
-
Patent Title: Systems and methods for adjusting electrical therapy based on impedance changes Oct. 03, 2017
-
Patent Title: Medical device communication and charging assemblies for use with implantable signal generators, and associated systems and methods Oct. 03, 2017
-
Patent Title: Systems and methods for systematically testing a plurality of therapy programs in patient therapy devices Aug. 15, 2017
-
Patent Title: Neurological stimulation lead anchors and associated systems and methods Jun. 27, 2017
-
Patent Title: Systems and methods for delivering neural therapy correlated with patient status Jun. 06, 2017
-
Patent Title: Devices for controlling spinal cord modulation for inhibiting pain, and associated systems and methods, including controllers for automated parameter selection Mar. 28, 2017
-
Patent Title: Devices for controlling high frequency spinal cord modulation for inhibiting pain, and associated systems and methods, including simplified contact selection Mar. 14, 2017
-
Patent Title: Systems and methods for selecting low-power, effective signal delivery parameters for an implanted pulse generator Dec. 13, 2016
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods Nov. 01, 2016
-
Patent Title: Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods Aug. 09, 2016
-
Patent Title: Linked area parameter adjustment for spinal cord stimulation and associated systems and methods Aug. 09, 2016
-
Patent Title: Modeling positions of implanted devices in a patient Aug. 02, 2016
-
Patent Title: Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions Aug. 02, 2016
-
Patent Title: Systems and methods for adjusting electrical therapy based on impedance changes Jul. 26, 2016
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods Jul. 12, 2016
-
Patent Title: Systems and methods for detecting intrathecal penetration Jun. 07, 2016
-
Patent Title: Systems and methods for positioning implanted devices in a patient May. 24, 2016
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods May. 10, 2016
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods May. 10, 2016
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods May. 10, 2016
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods May. 10, 2016
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods May. 03, 2016
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods May. 03, 2016
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods May. 03, 2016
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods May. 03, 2016
-
Patent Title: Lead insertion devices and associated systems and methods Apr. 12, 2016
-
Patent Title: Systems and methods for automatically programming patient therapy devices Mar. 29, 2016
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods Mar. 29, 2016
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods Mar. 15, 2016
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods Mar. 15, 2016
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods Mar. 08, 2016
-
Patent Title: Neurological stimulation lead anchors and associated systems and methods Feb. 23, 2016
-
Patent Title: Devices for controlling high frequency spinal cord modulation for inhibiting pain, and associated systems and methods, including simplified program selection Feb. 02, 2016
-
Patent Title: Molded headers for implantable signal generators, and associated systems and methods Jan. 05, 2016
-
Patent Title: Systems and methods for delivering neural therapy correlated with patient status Dec. 01, 2015
-
Patent Title: Implantable signal generator Aug. 18, 2015
-
Patent Title: Implantable signal generator Aug. 11, 2015
Federal grants, loans, and purchases
- $58,855 2024-06-17 00:00:00 Agency: Department of Veterans Affairs
- $58,855 2024-05-03 00:00:00 Agency: Department of Veterans Affairs
- $58,279 2024-01-26 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2024-01-23 00:00:00 Agency: None
- $38,950 2024-01-23 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2024-01-23 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2024-01-23 00:00:00 Agency: Department of Veterans Affairs
- $29,725 2023-12-18 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-11-24 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-11-03 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2023-10-25 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2023-10-25 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-09-25 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-09-25 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-09-09 00:00:00 Agency: Department of Veterans Affairs
- $43,024 2023-09-05 00:00:00 Agency: Department of Veterans Affairs
- $40,258 2023-08-18 00:00:00 Agency: Department of Veterans Affairs
- $37,900 2023-08-11 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-08-10 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-08-08 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2023-08-08 00:00:00 Agency: Department of Veterans Affairs
- $35,000 2023-08-01 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2023-07-13 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-07-13 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-07-13 00:00:00 Agency: Department of Veterans Affairs
- $38,825 2023-07-12 00:00:00 Agency: Department of Veterans Affairs
- $44,200 2023-07-07 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-07-03 00:00:00 Agency: Department of Veterans Affairs
- $36,225 2023-05-31 00:00:00 Agency: Department of Veterans Affairs
- $36,300 2023-05-30 00:00:00 Agency: Department of Veterans Affairs
- $37,450 2023-05-19 00:00:00 Agency: Department of Veterans Affairs
- $29,725 2023-05-19 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-05-09 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-05-09 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-05-09 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-04-24 00:00:00 Agency: Department of Veterans Affairs
- $31,775 2023-04-17 00:00:00 Agency: Department of Veterans Affairs
- $46,225 2023-04-12 00:00:00 Agency: Department of Veterans Affairs
- $29,975 2023-04-07 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-03-31 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-03-31 00:00:00 Agency: Department of Veterans Affairs
- $27,875 2023-03-28 00:00:00 Agency: Department of Veterans Affairs
- $29,975 2023-03-24 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-03-17 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-03-10 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-02-27 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $41,024 2023-02-17 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $33,250 2023-01-18 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $44,350 2023-01-09 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $36,950 2022-12-30 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
Estimated quarterly amount awarded to NVRO from public contracts
Recent insights relating to NVRO
Recent picks made for NVRO stock on CNBC
ETFs with the largest estimated holdings in NVRO
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $NVRO stock a Buy, Sell, or Hold?
- What is the price target for $NVRO stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $NVRO stock?
- Who owns the most shares of $NVRO stock?
- What funds own $NVRO stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view NVRO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
No description available